Skip to content
Equity

Non-Controlling Interests

Medtronic Non-Controlling Interests increased by 188.6% to $609M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 162.5%, from $232M to $609M. Over 5 years (FY 2021 to FY 2026), Non-Controlling Interests shows an upward trend with a 28.5% CAGR.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2016
Last reportedQ4 2026Jun 18, 2026

How to read this metric

Changes reflect the acquisition or divestiture of partial ownership stakes in subsidiaries.

Detailed definition

Noncontrolling interests represent the portion of equity in a consolidated subsidiary that is not owned by the parent co...

Peer comparison

Common for large conglomerates with complex subsidiary structures.

Metric ID: noncontrolling_interests

Historical Data

21 periods
 Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Value$174M$178M$168M$171M$171M$170M$177M$177M$182M$188M$187M$204M$206M$213M$222M$228M$232M$240M$204M$211M$609M
QoQ Change+2.3%-5.6%+1.8%+0.0%-0.6%+4.1%+0.0%+2.8%+3.3%-0.5%+9.1%+1.0%+3.4%+4.2%+2.7%+1.8%+3.4%-15.0%+3.4%+188.6%
YoY Change-1.7%-4.5%+5.4%+3.5%+6.4%+10.6%+5.6%+15.3%+13.2%+13.3%+18.7%+11.8%+12.6%+12.7%-8.1%-7.5%+162.5%
Range$168M$609M
CAGR+28.5%
Avg YoY Growth+15.9%
Median YoY Growth+10.6%
Current Streak2 quarters growth

Frequently Asked Questions

What is Medtronic's non-controlling interests?
Medtronic (MDT) reported non-controlling interests of $609M in Q1 2026.
How has Medtronic's non-controlling interests changed year-over-year?
Medtronic's non-controlling interests increased by 162.5% year-over-year, from $232M to $609M.
What is the long-term trend for Medtronic's non-controlling interests?
Over 5 years (2021 to 2026), Medtronic's non-controlling interests has grown at a 28.5% compound annual growth rate (CAGR), from $174M to $609M.
What does non-controlling interests mean?
The share of a subsidiary's equity owned by outside investors rather than the parent company.